A detailed history of Wahed Invest LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wahed Invest LLC holds 41,666 shares of ABT stock, worth $4.66 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
41,666
Previous 39,210 6.26%
Holding current value
$4.66 Million
Previous $4.07 Million 16.59%
% of portfolio
0.86%
Previous 0.83%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $245,771 - $290,127
2,456 Added 6.26%
41,666 $4.75 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $400,301 - $446,836
3,974 Added 11.28%
39,210 $4.07 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $620,321 - $685,117
5,664 Added 19.15%
35,236 $4 Million
Q4 2023

Mar 11, 2024

SELL
$90.19 - $110.4 $21.7 Million - $26.6 Million
-240,591 Reduced 89.05%
29,572 $3.25 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $21.9 Million - $26.8 Million
242,843 Added 888.88%
270,163 $29.7 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $240,640 - $288,727
2,519 Added 10.16%
27,320 $2.65 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $284,401 - $316,882
2,822 Added 12.84%
24,801 $2.7 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $19,856 - $23,372
-205 Reduced 0.92%
21,979 $2.23 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $240,406 - $282,034
2,529 Added 12.87%
22,184 $2.44 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $136,528 - $158,074
1,411 Added 7.73%
19,655 $1.9 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $225,778 - $272,894
-2,212 Reduced 10.81%
18,244 $1.98 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $41,047 - $50,054
-360 Reduced 1.73%
20,456 $2.42 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $2.4 Million - $2.94 Million
20,816 New
20,816 $2.93 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $196B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Wahed Invest LLC Portfolio

Follow Wahed Invest LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wahed Invest LLC with notifications on news.